Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase1B Study: A Placebo Controlled Study of PF-03654746 Given as Add-On Treatment of Cognitive Deficits in Schizophrenia

NCT01346163 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01346163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01346163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase1B Study: A Placebo Controlled Study of PF-03654746 Given as Add-On Treatment of Cognitive Deficits in Schizophrenia
Lead sponsor
University of Pennsylvania
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
November 30, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia